Single domain intracellular antibodies: A minimal fragment for direct in vivo selection of antigen-specific intrabodies

Journal of Molecular Biology

Volumn 331, Issue 5, 2003, Pages 1109-1120

  Tanaka, Tomoyuki ^a   Lobato, M Natividad ^a   Rabbitts, Terence H ^a  

^a MRC LABORATORY OF MOLECULAR BIOLOGY   (United Kingdom)

Author keywords

Cancer therapy; In vivo selection; Intrabody; Library; Single VH domain antibody

Indexed keywords

ANTIBODY; ANTIGEN; IMMUNOGLOBULIN; RAS PROTEIN;

ANIMAL CELL; ANTIBODY LIBRARY; ANTIGEN SPECIFICITY; ARTICLE; BIOTRANSFORMATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN TARGETING; SCREENING; VALIDATION PROCESS;

EID: 0043123378     PISSN: 00222836     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-2836(03)00836-2     Document Type: Article

References (42)

1. Trail P.A., Bianchi A.B. Monoclonal antibody drug conjugates in the treatment of cancer. Curr. Opin. Immunol. 11:1999;584-588.
2. Segal D.M., Weiner G.J., Weiner L.M. Bispecific antibodies in cancer therapy. Curr. Opin. Immunol. 11:1999;558-562.
3. Rabbitts T.H., Stocks M.R. Chromosomal translocation products engender novel intracellular therapeutic technologies. Nature Med. 9:2003;383-386.
4. Collins F.S., et al. New goals for the US Human Genome Project: 1998-2003. Science. 282:1998;682-689.
5. Tuschl T. Expanding small RNA interference. Nature Biotechnol. 20:2002;446-448.
6. Cattaneo A., Biocca S. The selection of intracellular antibodies. Trends Biotechnol. 17:1999;115-121.
7. Rondon I.J., Marasco W.A. Intracellular antibodies (intrabodies) for gene therapy of infectious diseases. Annu. Rev. Microbiol. 51:1997;257-283.
8. Bird R.E., Hardman K.D., Jacobson J.W., Johnson S., Kaufman B.M., Lee S.-M., et al. Single-chain antigen-binding proteins. Science. 242:1988;423-426.
9. Huston J.S., Levinson D., Mudgett-Hunter M., Tai M.-S., Novoty J., Margolies M.N., et al. Protein engineering of antibody binding sites: Recovery of specific activity in an anti-digoxin single-chain Fv analogue produced in Escherichia coli. Proc. Natl Acad. Sci. USA. 85:1988;5879-5883.
10. Biocca S., Pierandrei-Amaldi P., Cattaneo A. Intracellular expression of anti-p21ras single chain Fv fragments inhibits meiotic maturation of xenopus oocytes. Biochem. Biophys. Res. Commun. 197:1993;422-427.
11. Tavladoraki P., Benvenuto E., Trinca S., De Martinis D., Cattaneo A., Galeffi P. Transgenic plants expressing a functional single-chain Fv antibody are specifically protected from virus attack. Nature. 366:1993;469-472.
12. Proba K., Worn A., Honegger A., Pluckthun A. Antibody scFv fragments without disulfide bonds made by molecular evolution. J. Mol. Biol. 275:1998;245-253.
13. Worn A., Pluckthun A. Mutual stabilization of VL and VH in single-chain antibody fragments, investigated with mutants engineered for stability. Biochemistry. 37:1998;13120-13127.
14. Visintin M., et al. Selection of antibodies for intracellular function using a two-hybrid in vivo system. Proc. Natl Acad. Sci. USA. 96:1999;11723-11728.
15. Tse E., Lobato M.N., Forster A., Tanaka T., Chung G.T.Y., Rabbitts T.H. Intracellular antibody capture technology: application to selection of single chain Fv recognising the BCR-ABL oncogenic protein. J. Mol. Biol. 317:2002;85-94.
16. Visintin M., Settanni G., Maritan A., Graziosi S., Marks J.D., Cattaneo A. The intracellular antibody capture technology (IACT): towards a consensus sequence for intracellular antibodies. J. Mol. Biol. 317:2002;73-83.
17. Tanaka T., Rabbitts T.H. Intrabodies based on intracellular capture frameworks that bind the RAS protein with high affinity and impair oncogenic transformation. EMBO J. 22:2003;1025-1035.
18. Ward E.S., Gussow D., Griffiths A.D., Jones P.T., Winter G. Binding activities of a repertoire of single immunoglobulin variable domains secreted from Escherichia coli. Nature. 341:1989;544-546.
19. Davies J., Riechmann L. Single antibody domains as small recognition units: design and in vitro antigen selection of camelized, human VH domains with improved protein stability. Protein Eng. 9:1996;531-537.
20. Reiter Y., Schuck P., Boyd L.F., Plaksin D. An antibody single-domain phage display library of a native heavy chain variable region: isolation of functional single-domain VH molecules with a unique interface. J. Mol. Biol. 290:1999;685-698.
21. Tanaka T., Chung G.T.Y., Forster A., Lobato M.N., Rabbitts T.H. De novo production of diverse intracellular antibody libraries. Nucl. Acids Res. 31:2003;e23.
22. Tse E., Chung G., Rabbitts T.H. Isolation of antigen-specific intracellular antibody fragments as single chain Fv for use in mammalian cells. Turksen K. Methods in Molecular Biology and Medicine. 2000;433-446 Humana Press, Totawa.
23. Fearon E.R., Finkel T., Gillison M.L., Kennedy S.P., Casella J.F., Tomaselli G.F., et al. Karyoplasmic interaction selection strategy: a general strategy to detect protein-protein interaction in mammalian cells. Proc. Natl Acad. Sci. USA. 89:1992;7958-7962.
24. Martineau P., Jones P., Winter G. Expression of an antibody fragment at high levels in the bacterial cytoplasm. J. Mol. Biol. 280:1998;117-127.
25. Davies J., Riechmann L. Antibody VH domains as small recognition units. Biotechnology (NY). 13:1995;475-479.
26. Riechmann L., Muyldermans S. Single domain antibodies: comparison of camel VH and camelised human VH domains. J. Immunol. Methods. 231:1999;25-38.
27. Glockshuber R., Malia M., Pfitzinger I., Pluckthun A. A comparison of strategies to stabilize immunoglobulin Fv-fragments. Biochemistry. 29:1990;1362-1367.
28. Reiter Y., Pastan I. Antibody engineering of recombinant Fv immunotoxins for improved targeting of cancer: disulfide-stabilized Fv immunotoxins. Clin. Cancer Res. 2:1996;245-252.
29. Muyldermans S., Cambillau C., Wyns L. Recognition of antigens by single-domain antibody fragments: the superfluous luxury of paired domains. Trends Biochem. Sci. 26:2001;230-235.
30. Muyldermans S., Atarhouch T., Saldanha J., Barbosa J.A., Hamers R. Sequence and structure of VH domain from naturally occurring camel heavy chain immunoglobulins lacking light chains. Protein Eng. 7:1994;1129-1135.
31. de Wet J.R., Wood K.V., DeLuca M., Helinski D.R., Subramani S. Firefly luciferase gene: structure and expression in mammalian cells. Mol. Cell. Biol. 7:1987;725-737.
32. Shioda T., Andriole S., Yahata T., Isselbacher K.J. A green fluorescent protein-reporter mammalian two-hybrid system with extrachromosomal maintenance of a prey expression plasmid: application to interaction screening. Proc. Natl Acad. Sci. USA. 97:2000;5220-5224.
33. Portner-Taliana A., Russell M., Froning K.J., Budworth P.R., Comiskey J.D., Hoeffler J.P. In vivo selection of single-chain antibodies using a yeast two-hybrid system. J. Immunol. Methods. 238:2000;161-172.
34. Sadowski I., Bell B., Broad P., Hollis M. GAL4 fusion vectors for expression in yeast or mammalian cells. Gene. 118:1992;137-141.
35. Hollenberg S.M., Sternglanz R., Cheng P.F., Weintraub H. Identification of a new family of tissue-specific basic helix-loop-helix proteins with a two-hybrid system. Mol. Cell. Biol. 15:1995;3813-3822.
36. Cepko C.L., Roberts B.E., Mulligan R.C. Construction and applications of a highly transmissible murine retrovirus shuttle vector. Cell. 37:1984;1053-1062.
37. Hoogenboom H.R., Winter G. By-passing immunisation. Human antibodies from synthetic repertoires of germline VH gene segments rearranged in vitro. J. Mol. Biol. 227:1992;381-388.
38. Tse E., Rabbitts T.H. Intracellular antibody-caspase mediated cell killing: a novel approach for application in cancer therapy. Proc. Natl Acad. Sci. USA. 97:2000;12266-12271.
39. Lefranc M.P. IMGT, the international ImMunoGeneTics database: a high-quality information system for comparative immunogenetics and immunology. Dev. Comp. Immunol. 26:2002;697-705.
40. Lefranc M.P., Pommie C., Ruiz M., Giudicelli V., Foulquier E., Truong L., et al. IMGT unique numbering for immunoglobulin and T cell receptor variable domains and Ig superfamily V-like domains. Dev. Comp. Immunol. 27:2003;55-77.
41. Lefranc M.-P., Lefranc G. The Immunoglobulin FactsBook. 2001;Academic Press, London.
42. Kabat E.A., Wu T.T., Perry H.M., Gottesman K.S., Foeller C. Sequences of Proteins of Immunological Interest. 5th edit. 1991;National Institutes of Health, Bethesda.